CA2855748C - Primers, probes and methods for nucleic acid amplification - Google Patents
Primers, probes and methods for nucleic acid amplification Download PDFInfo
- Publication number
- CA2855748C CA2855748C CA2855748A CA2855748A CA2855748C CA 2855748 C CA2855748 C CA 2855748C CA 2855748 A CA2855748 A CA 2855748A CA 2855748 A CA2855748 A CA 2855748A CA 2855748 C CA2855748 C CA 2855748C
- Authority
- CA
- Canada
- Prior art keywords
- pcr
- primer
- late
- probe
- amplification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000003199 nucleic acid amplification method Methods 0.000 title claims description 163
- 230000003321 amplification Effects 0.000 title claims description 157
- 238000000034 method Methods 0.000 title claims description 118
- 239000000523 sample Substances 0.000 title abstract description 393
- 150000007523 nucleic acids Chemical class 0.000 title description 16
- 102000039446 nucleic acids Human genes 0.000 title description 15
- 108020004707 nucleic acids Proteins 0.000 title description 15
- 238000012163 sequencing technique Methods 0.000 claims abstract description 109
- 108020004414 DNA Proteins 0.000 claims description 153
- 238000006243 chemical reaction Methods 0.000 claims description 138
- 238000012175 pyrosequencing Methods 0.000 claims description 78
- 102000053602 DNA Human genes 0.000 claims description 66
- 108091034117 Oligonucleotide Proteins 0.000 claims description 57
- 239000003153 chemical reaction reagent Substances 0.000 claims description 42
- 102000004190 Enzymes Human genes 0.000 claims description 40
- 108090000790 Enzymes Proteins 0.000 claims description 40
- 108020004682 Single-Stranded DNA Proteins 0.000 claims description 39
- 239000000758 substrate Substances 0.000 claims description 25
- 230000000694 effects Effects 0.000 claims description 19
- 102000009609 Pyrophosphatases Human genes 0.000 claims description 16
- 108010009413 Pyrophosphatases Proteins 0.000 claims description 16
- 108010007730 Apyrase Proteins 0.000 claims description 11
- 102000007347 Apyrase Human genes 0.000 claims description 11
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 10
- 235000011180 diphosphates Nutrition 0.000 claims description 10
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 102100034289 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Human genes 0.000 claims description 5
- 101710103779 Deoxynucleoside triphosphate triphosphohydrolase SAMHD1 Proteins 0.000 claims description 5
- 244000061456 Solanum tuberosum Species 0.000 claims description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 4
- 238000012408 PCR amplification Methods 0.000 abstract description 99
- 238000001514 detection method Methods 0.000 abstract description 79
- 238000004458 analytical method Methods 0.000 abstract description 38
- 238000005464 sample preparation method Methods 0.000 abstract description 4
- 238000011002 quantification Methods 0.000 abstract description 3
- 239000013615 primer Substances 0.000 description 350
- 239000000047 product Substances 0.000 description 156
- 239000000975 dye Substances 0.000 description 123
- 238000002844 melting Methods 0.000 description 87
- 230000008018 melting Effects 0.000 description 87
- 108091093088 Amplicon Proteins 0.000 description 70
- 239000000203 mixture Substances 0.000 description 69
- 230000000670 limiting effect Effects 0.000 description 66
- 238000003556 assay Methods 0.000 description 62
- 108700028369 Alleles Proteins 0.000 description 60
- 238000003752 polymerase chain reaction Methods 0.000 description 59
- 239000011541 reaction mixture Substances 0.000 description 48
- 239000002773 nucleotide Substances 0.000 description 39
- 125000003729 nucleotide group Chemical group 0.000 description 39
- 230000000295 complement effect Effects 0.000 description 32
- 238000009396 hybridization Methods 0.000 description 29
- 238000002360 preparation method Methods 0.000 description 27
- 238000000137 annealing Methods 0.000 description 24
- 238000007792 addition Methods 0.000 description 23
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 18
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 18
- 238000002944 PCR assay Methods 0.000 description 18
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 18
- 239000002987 primer (paints) Substances 0.000 description 18
- 238000010790 dilution Methods 0.000 description 17
- 239000012895 dilution Substances 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 16
- 108010006785 Taq Polymerase Proteins 0.000 description 14
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 14
- 229910052737 gold Inorganic materials 0.000 description 14
- 239000010931 gold Substances 0.000 description 14
- 230000036961 partial effect Effects 0.000 description 14
- 238000003205 genotyping method Methods 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- 241000187474 Mycobacterium asiaticum Species 0.000 description 12
- CGNLCCVKSWNSDG-UHFFFAOYSA-N SYBR Green I Chemical compound CN(C)CCCN(CCC)C1=CC(C=C2N(C3=CC=CC=C3S2)C)=C2C=CC=CC2=[N+]1C1=CC=CC=C1 CGNLCCVKSWNSDG-UHFFFAOYSA-N 0.000 description 12
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 241000187484 Mycobacterium gordonae Species 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 238000010791 quenching Methods 0.000 description 11
- 238000010606 normalization Methods 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 9
- 238000012937 correction Methods 0.000 description 9
- 229910052697 platinum Inorganic materials 0.000 description 9
- 238000000746 purification Methods 0.000 description 9
- 108060001084 Luciferase Proteins 0.000 description 8
- 239000005089 Luciferase Substances 0.000 description 8
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 8
- 238000009825 accumulation Methods 0.000 description 8
- 230000008859 change Effects 0.000 description 8
- 230000005284 excitation Effects 0.000 description 8
- 238000010348 incorporation Methods 0.000 description 8
- 238000012544 monitoring process Methods 0.000 description 8
- 230000035772 mutation Effects 0.000 description 8
- 230000000171 quenching effect Effects 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 108020005196 Mitochondrial DNA Proteins 0.000 description 7
- 108091007416 X-inactive specific transcript Proteins 0.000 description 7
- 108091035715 XIST (gene) Proteins 0.000 description 7
- 230000027455 binding Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 7
- 239000007850 fluorescent dye Substances 0.000 description 7
- 238000011880 melting curve analysis Methods 0.000 description 7
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 7
- 108020004465 16S ribosomal RNA Proteins 0.000 description 6
- IGXWBGJHJZYPQS-SSDOTTSWSA-N D-Luciferin Chemical compound OC(=O)[C@H]1CSC(C=2SC3=CC=C(O)C=C3N=2)=N1 IGXWBGJHJZYPQS-SSDOTTSWSA-N 0.000 description 6
- CYCGRDQQIOGCKX-UHFFFAOYSA-N Dehydro-luciferin Natural products OC(=O)C1=CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 CYCGRDQQIOGCKX-UHFFFAOYSA-N 0.000 description 6
- BJGNCJDXODQBOB-UHFFFAOYSA-N Fivefly Luciferin Natural products OC(=O)C1CSC(C=2SC3=CC(O)=CC=C3N=2)=N1 BJGNCJDXODQBOB-UHFFFAOYSA-N 0.000 description 6
- DDWFXDSYGUXRAY-UHFFFAOYSA-N Luciferin Natural products CCc1c(C)c(CC2NC(=O)C(=C2C=C)C)[nH]c1Cc3[nH]c4C(=C5/NC(CC(=O)O)C(C)C5CC(=O)O)CC(=O)c4c3C DDWFXDSYGUXRAY-UHFFFAOYSA-N 0.000 description 6
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 6
- 241000187492 Mycobacterium marinum Species 0.000 description 6
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 6
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 239000007795 chemical reaction product Substances 0.000 description 6
- 102000042567 non-coding RNA Human genes 0.000 description 6
- 238000005382 thermal cycling Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 108060002716 Exonuclease Proteins 0.000 description 5
- 241000187493 Mycobacterium malmoense Species 0.000 description 5
- 102000004523 Sulfate Adenylyltransferase Human genes 0.000 description 5
- 108010022348 Sulfate adenylyltransferase Proteins 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- IRLPACMLTUPBCL-FCIPNVEPSA-N adenosine-5'-phosphosulfate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@@H](CO[P@](O)(=O)OS(O)(=O)=O)[C@H](O)[C@H]1O IRLPACMLTUPBCL-FCIPNVEPSA-N 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 238000013211 curve analysis Methods 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000013461 design Methods 0.000 description 5
- 102000013165 exonuclease Human genes 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 238000009830 intercalation Methods 0.000 description 5
- 239000000155 melt Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- 201000003883 Cystic fibrosis Diseases 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- 238000003705 background correction Methods 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 238000003366 endpoint assay Methods 0.000 description 4
- 239000001046 green dye Substances 0.000 description 4
- 210000004919 hair shaft Anatomy 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000002076 thermal analysis method Methods 0.000 description 4
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 3
- 102100036243 HLA class II histocompatibility antigen, DQ alpha 1 chain Human genes 0.000 description 3
- 108010086786 HLA-DQA1 antigen Proteins 0.000 description 3
- 108010053317 Hexosaminidase A Proteins 0.000 description 3
- 108091028043 Nucleic acid sequence Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 238000007846 asymmetric PCR Methods 0.000 description 3
- 238000005251 capillar electrophoresis Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 230000009089 cytolysis Effects 0.000 description 3
- 238000000295 emission spectrum Methods 0.000 description 3
- 238000012869 ethanol precipitation Methods 0.000 description 3
- 238000001917 fluorescence detection Methods 0.000 description 3
- 210000003917 human chromosome Anatomy 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 229910001629 magnesium chloride Inorganic materials 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000001308 synthesis method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102100022548 Beta-hexosaminidase subunit alpha Human genes 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 238000009004 PCR Kit Methods 0.000 description 2
- 108091093037 Peptide nucleic acid Proteins 0.000 description 2
- 208000022292 Tay-Sachs disease Diseases 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 150000001768 cations Chemical class 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 239000005546 dideoxynucleotide Substances 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- LIYGYAHYXQDGEP-UHFFFAOYSA-N firefly oxyluciferin Natural products Oc1csc(n1)-c1nc2ccc(O)cc2s1 LIYGYAHYXQDGEP-UHFFFAOYSA-N 0.000 description 2
- 238000001502 gel electrophoresis Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N guanidine group Chemical group NC(=N)N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000007403 mPCR Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002853 nucleic acid probe Substances 0.000 description 2
- 230000005257 nucleotidylation Effects 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- JJVOROULKOMTKG-UHFFFAOYSA-N oxidized Photinus luciferin Chemical compound S1C2=CC(O)=CC=C2N=C1C1=NC(=O)CS1 JJVOROULKOMTKG-UHFFFAOYSA-N 0.000 description 2
- 108700025694 p53 Genes Proteins 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000003595 spectral effect Effects 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 2
- DILISPNYIVRDBP-UHFFFAOYSA-N 2-[3-[2-(2-hydroxypropylamino)pyrimidin-4-yl]-2-naphthalen-2-ylimidazol-4-yl]acetonitrile Chemical compound OC(CNC1=NC=CC(=N1)N1C(=NC=C1CC#N)C1=CC2=CC=CC=C2C=C1)C DILISPNYIVRDBP-UHFFFAOYSA-N 0.000 description 1
- 101100020619 Arabidopsis thaliana LATE gene Proteins 0.000 description 1
- 108091035707 Consensus sequence Proteins 0.000 description 1
- 108020001019 DNA Primers Proteins 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 102000016871 Hexosaminidase A Human genes 0.000 description 1
- 101100177568 Homo sapiens HEXA gene Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 241000276420 Lophius piscatorius Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 108010006886 Vitrogen Proteins 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000012197 amplification kit Methods 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000001818 capillary gel electrophoresis Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001506 fluorescence spectroscopy Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000003068 molecular probe Substances 0.000 description 1
- 238000007837 multiplex assay Methods 0.000 description 1
- 238000011328 necessary treatment Methods 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000010223 real-time analysis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000010839 reverse transcription Methods 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000012898 sample dilution Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 108010068698 spleen exonuclease Proteins 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6851—Quantitative amplification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA2996947A CA2996947C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US61965404P | 2004-10-18 | 2004-10-18 | |
| US60/619,654 | 2004-10-18 | ||
| CA2584569A CA2584569C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2584569A Division CA2584569C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2996947A Division CA2996947C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2855748A1 CA2855748A1 (en) | 2006-04-27 |
| CA2855748C true CA2855748C (en) | 2018-08-28 |
Family
ID=36203686
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2855748A Expired - Fee Related CA2855748C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
| CA2584569A Expired - Fee Related CA2584569C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
| CA2996947A Expired - Fee Related CA2996947C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2584569A Expired - Fee Related CA2584569C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
| CA2996947A Expired - Fee Related CA2996947C (en) | 2004-10-18 | 2005-10-17 | Primers, probes and methods for nucleic acid amplification |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US7632642B2 (enExample) |
| EP (3) | EP1805199B1 (enExample) |
| JP (2) | JP5543065B2 (enExample) |
| KR (3) | KR101424812B1 (enExample) |
| CN (1) | CN101076607B (enExample) |
| AT (1) | ATE494295T1 (enExample) |
| AU (1) | AU2005295298B2 (enExample) |
| BR (1) | BRPI0517105B1 (enExample) |
| CA (3) | CA2855748C (enExample) |
| DE (1) | DE602005025791D1 (enExample) |
| DK (1) | DK1805199T3 (enExample) |
| ES (3) | ES2668467T3 (enExample) |
| NO (1) | NO20072506L (enExample) |
| PL (1) | PL1805199T3 (enExample) |
| PT (1) | PT1805199E (enExample) |
| RU (1) | RU2460804C2 (enExample) |
| WO (1) | WO2006044994A2 (enExample) |
Families Citing this family (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101424812B1 (ko) | 2004-10-18 | 2014-08-07 | 브랜데이스 유니버시티 | 핵산 증폭을 위한 프라이머, 프로브 및 방법 |
| CN100487432C (zh) * | 2006-06-22 | 2009-05-13 | 上海交通大学 | 采用分子信标对核酸信号进行恒温放大与检测的方法 |
| US7933011B2 (en) | 2007-07-12 | 2011-04-26 | Smiths Detection Inc. | Fiber optic detection system |
| CN101910410A (zh) * | 2007-10-23 | 2010-12-08 | 斯特拉托斯基因公司 | 通过间隔进行高通量核酸测序 |
| US8538733B2 (en) * | 2008-01-25 | 2013-09-17 | Life Technologies Corporation | Methods for the analysis of dissociation melt curve data |
| US20100129796A1 (en) * | 2008-11-24 | 2010-05-27 | Micah Halpern | Dye probe fluorescence resonance energy transfer genotyping |
| US9856522B2 (en) | 2008-12-30 | 2018-01-02 | Stmicroelectronics S.R.L. | Method, microreactor and apparatus for carrying out real-time nucleic acid amplification |
| FR2940805B1 (fr) * | 2009-01-05 | 2015-10-16 | Biomerieux Sa | Procede d'amplification et/ou de detection d'acides nucleiques, kits et utilisations de ce procede |
| JP5423006B2 (ja) * | 2009-01-20 | 2014-02-19 | ソニー株式会社 | プライマー評価方法、プライマー評価プログラム及びリアルタイムｐｃｒ装置 |
| US8039215B2 (en) * | 2009-03-10 | 2011-10-18 | Roche Molecular Systems, Inc. | Multiplex quantitative nucleic acid amplification and melting assay |
| US9034605B2 (en) | 2009-03-12 | 2015-05-19 | Brandeis University | Reagents and methods for PCR |
| US8674080B2 (en) | 2009-04-09 | 2014-03-18 | Roche Molecular Systems, Inc. | Dye composition for liquid transfer control |
| FI20095514A0 (fi) * | 2009-05-07 | 2009-05-07 | Expression Analytics Oy | Menetelmä, laitteisto ja tietokoneohjelmatuote PCR-tuotteiden kvantifioimiseksi |
| DE102009026651A1 (de) * | 2009-06-02 | 2011-02-17 | Großmann, Kay, Dr. rer. nat. (Chemie) | Verfahren und Messvorrichtung zur qualitativen und quantitativen Analyse von Körperflüssigkeiten |
| AR077840A1 (es) | 2009-08-11 | 2011-09-28 | Univ Brandeis | Ensayos de deteccion e identificacion de especies y tipos de staphylococcus |
| AR077841A1 (es) | 2009-08-11 | 2011-09-28 | Univ Brandeis | Metodos kits y composiciones de deteccion de acido nucleico a multiples temperaturas, con sonda unica |
| CN102471364B (zh) * | 2009-08-14 | 2015-01-14 | 株式会社日立制作所 | 基因序列分析的方法和试剂 |
| EP2980224B1 (en) | 2009-10-21 | 2019-07-03 | Brandeis University | Kits for analyzing single-stranded nucleic acid sequences |
| EP2496715B1 (en) * | 2009-11-03 | 2016-01-27 | HTG Molecular Diagnostics, Inc. | Quantitative nuclease protection sequencing (qnps) |
| EP2569447A4 (en) * | 2010-05-14 | 2013-11-27 | Fluidigm Corp | ASSAYS FOR THE DETECTION OF GENOTYPES, MUTATIONS OR ANEUPLOIDY |
| IT1405994B1 (it) * | 2010-06-22 | 2014-02-06 | Euroclone Spa | Metodo ad elevata sensibilita' per rilevare un acido nucleico target in un campione |
| EP2606150B1 (en) * | 2010-08-20 | 2016-03-16 | Life Technologies Corporation | Quantitative real-time pcr assay using fret dual-labeled primers |
| US9850529B2 (en) | 2010-09-08 | 2017-12-26 | Brandeis University | Compositions and methods for nucleic acid based diagnostic assays for variable sequence targets |
| US9309556B2 (en) | 2010-09-24 | 2016-04-12 | The Board Of Trustees Of The Leland Stanford Junior University | Direct capture, amplification and sequencing of target DNA using immobilized primers |
| US20130295570A1 (en) * | 2010-10-07 | 2013-11-07 | Brandeis University | Compositions and methods for nucleic acid based diagnostic assays |
| GB201017978D0 (en) * | 2010-10-25 | 2010-12-08 | Oxitec Ltd | Multiplex amplification and detection |
| US10273525B2 (en) | 2010-11-10 | 2019-04-30 | Brandeis University | Compositions, methods, and kits for detecting and identifying mycobacteria |
| WO2012075230A1 (en) | 2010-12-03 | 2012-06-07 | Brandeis University | Detecting mutations in dna |
| EP2649201A4 (en) * | 2010-12-10 | 2014-10-01 | Univ Brandeis | COMPOSITIONS AND METHODS FOR DETECTING AND ANALYZING AFRICAN SWINE FEVER |
| EP3181704B1 (en) | 2010-12-27 | 2021-01-27 | Abbott Molecular Inc. | Quantitating high titer samples by digital pcr |
| WO2012095748A2 (en) * | 2011-01-14 | 2012-07-19 | Smiths Detection - Watford Limited | Single tube quantitative polymerase chain reaction (pcr) |
| CN103649335B (zh) | 2011-05-04 | 2015-11-25 | Htg分子诊断有限公司 | 定量核酸酶保护测定（qnpa）和测序（qnps）的改进 |
| US20150031024A1 (en) * | 2011-07-30 | 2015-01-29 | The Regents Of The University Of California | Enzymatic preparation of 10 base to 50 kb double-strand dna reagent for sequencing with a nanopore-polymerase sequencing device |
| US20130052650A1 (en) | 2011-08-29 | 2013-02-28 | Thermo Fisher Scientific Inc. | Dye blends |
| CN102321765B (zh) * | 2011-09-08 | 2014-04-02 | 厦门基科生物科技有限公司 | 一种实时荧光pcr方法及用途 |
| CA2849023C (en) | 2011-09-15 | 2022-07-19 | David A. Shafer | Probe:antiprobe compositions for high specificity dna or rna detection |
| CN104024433B (zh) * | 2011-10-31 | 2016-11-16 | 爱科来株式会社 | 基因丰度的测定方法 |
| CN104271767B (zh) | 2012-02-03 | 2017-08-25 | 加州理工学院 | 多路生化测定中信号的编码和解码 |
| WO2013131083A1 (en) | 2012-03-02 | 2013-09-06 | Winthrop-University Hospital | METHOD FOR USING PROBE BASED PCR DETECTION TO MEASURE THE LEVELS OF CIRCULATING DEMETHYLATED β CELL DERIVED DNA AS A MEASURE OF β CELL LOSS IN DIABETES |
| CN102643910B (zh) * | 2012-04-10 | 2014-10-15 | 中国人民解放军第三军医大学第一附属医院 | 非对称多色荧光发夹探针链反应在病原菌检测中的应用 |
| IN2015DN01609A (enExample) | 2012-08-03 | 2015-07-03 | California Inst Of Techn | |
| WO2014043660A2 (en) * | 2012-09-17 | 2014-03-20 | Brandeis University | Combination of dsdna binding dye and probes for characterization of ssdna sequences |
| CA2902207A1 (en) * | 2013-02-21 | 2014-08-28 | Toma Biosciences, Inc. | Methods, compositions, and kits for nucleic acid analysis |
| EP2971095B1 (en) | 2013-03-12 | 2019-11-20 | Life Technologies Corporation | Universal reporter-based genotyping methods, reaction mixture and kit |
| CN105378160B (zh) | 2013-08-12 | 2018-04-17 | 伯乐生命医学产品有限公司 | 具有碱基配对的寡聚体的扩增报告子 |
| DK3052658T3 (da) * | 2013-09-30 | 2021-06-07 | Vesicode Ab | Fremgangsmåder til profilering af molekylkomplekser ved anvendelse af proksimitetsafhængig stregkodning |
| US10501783B2 (en) | 2013-12-11 | 2019-12-10 | Qiagen Gmbh | Nucleic acid detection and quantification |
| WO2015138343A1 (en) | 2014-03-10 | 2015-09-17 | Click Diagnostics, Inc. | Cartridge-based thermocycler |
| WO2015147370A1 (en) | 2014-03-28 | 2015-10-01 | Seegene, Inc. | Detection of target nucleic acid sequences using different detection temperatures |
| GB201411567D0 (en) | 2014-06-30 | 2014-08-13 | Epistem Ltd | Quantification methods |
| US20170247745A1 (en) * | 2014-09-12 | 2017-08-31 | Click Diagnostics, Inc. | Multiplex optical detection |
| CN116042880A (zh) | 2014-10-10 | 2023-05-02 | 新泽西鲁特格斯州立大学 | 结核分枝杆菌的聚合酶链反应引物和探针 |
| US10876155B2 (en) | 2014-12-09 | 2020-12-29 | Seegene, Inc. | Differentiation of signals for target nucleic acid sequences |
| EP3234186A1 (en) | 2014-12-19 | 2017-10-25 | Brandeis University | Mispriming prevention reagents |
| EP3240906B1 (en) | 2014-12-31 | 2021-08-25 | Visby Medical, Inc. | Devices for molecular diagnostic testing |
| WO2016115001A2 (en) * | 2015-01-12 | 2016-07-21 | Life Technologies Corporation | Methods, systems and compositions thereof for nucleic acid library quality control and quantification |
| EP3353697B1 (en) * | 2015-09-24 | 2025-11-05 | Seegene, Inc. | Multiple dataset analysis for determining the presence or absence of target analyte |
| WO2017087943A1 (en) | 2015-11-20 | 2017-05-26 | Brandeis University | Amplifying and detecting coconut cadang-cadang viroid rna |
| WO2017197040A1 (en) | 2016-05-11 | 2017-11-16 | Click Diagnostics, Inc. | Devices and methods for nucleic acid extraction |
| KR102326604B1 (ko) * | 2016-06-02 | 2021-11-15 | 주식회사 씨젠 | 신호 변화량 데이터 세트를 이용한 샘플 내 타겟 분석물질 검출 방법 |
| WO2018005710A1 (en) | 2016-06-29 | 2018-01-04 | Click Diagnostics, Inc. | Devices and methods for the detection of molecules using a flow cell |
| JP6983906B2 (ja) * | 2017-04-11 | 2021-12-17 | ニューゲン テクノロジーズ， インコーポレイテッド | ライブラリーの定量および定性 |
| US12492430B2 (en) | 2017-04-11 | 2025-12-09 | Tecan Genomics, Inc. | Library quantitation and qualification |
| US20190093155A1 (en) * | 2017-05-25 | 2019-03-28 | Roche Molecular Systems, Inc. | Multiplex Nucleic Acid Amplification Assay |
| EP3676400A4 (en) * | 2017-08-31 | 2021-06-02 | Seegene, Inc. | EVALUATING THE PERFORMANCE OF COMPONENTS USING A PAIR OF DIMERING PRIMERS |
| WO2019094784A1 (en) | 2017-11-09 | 2019-05-16 | Click Diagnostics, Inc. | Portable molecular diagnostic device and methods for the detection of target viruses |
| CN108570495A (zh) * | 2018-01-15 | 2018-09-25 | 新开源博畅（武汉）生物科技有限公司 | 一种hla高分辨基因位点的快速扩增诊断试剂盒及扩增方法 |
| CN108624664B (zh) * | 2018-01-16 | 2020-08-28 | 武汉菲思特生物科技有限公司 | 一种急性肝损伤的早期诊断标志物的快速扩增方法 |
| JP2021511056A (ja) | 2018-01-22 | 2021-05-06 | ルミネックス コーポレーション | 不連続融解分析のための方法および組成物 |
| WO2019204357A1 (en) | 2018-04-17 | 2019-10-24 | ChromaCode, Inc. | Methods and systems for multiplex analysis |
| BR112020019755A2 (pt) * | 2018-04-20 | 2021-01-26 | Seegene, Inc. | método e aparelho para detectar uma pluralidade de sequências de ácidos nucleicos alvo na amostra |
| US12203129B2 (en) | 2018-07-03 | 2025-01-21 | ChromaCode, Inc. | Formulations and signal encoding and decoding methods for massively multiplexed biochemical assays |
| US12239993B2 (en) | 2018-09-03 | 2025-03-04 | Visby Medical, Inc. | Devices and methods for antibiotic susceptibility testing |
| CN109321672B (zh) * | 2018-10-30 | 2021-07-06 | 中国农业大学 | 核苷酸组合物、试剂盒及检测方法 |
| KR20220005009A (ko) | 2019-04-28 | 2022-01-12 | 비스비 메디컬, 인코포레이티드 | 디지털 검출 능력 및 무선 연결성을 갖는 분자 진단 디바이스 |
| WO2021011850A2 (en) * | 2019-07-17 | 2021-01-21 | Chao Chien Chung | Amplification assay for the detection of anaplasma phagocytophilum |
| CN110568175A (zh) * | 2019-09-06 | 2019-12-13 | 成都理工大学 | 一种基于核酸染料诱导纳米金快速聚集检测dna的方法 |
| US20220340981A1 (en) | 2019-09-23 | 2022-10-27 | Universiteit Gent | Probe and method for str-genotyping |
| WO2021138544A1 (en) | 2020-01-03 | 2021-07-08 | Visby Medical, Inc. | Devices and methods for antibiotic susceptibility testing |
| US20230242971A1 (en) * | 2020-05-08 | 2023-08-03 | Roche Sequencing Solutions, Inc. | Removal of excess oligonucleotides from a reation mixture |
| CN111909990B (zh) * | 2020-08-28 | 2023-11-28 | 亚能生物技术（深圳）有限公司 | 单管同时检测基因的缺失突变和点突变的荧光pcr检测方法 |
| CN111961717B (zh) * | 2020-08-28 | 2023-08-01 | 南方医科大学 | 单管同时检测缺失型和非缺失型α-地中海贫血基因的荧光PCR试剂盒 |
| US20230068047A1 (en) * | 2021-08-19 | 2023-03-02 | Luminex Corporation | Digital amplification assay analysis method |
| EP4541906A1 (en) * | 2022-06-20 | 2025-04-23 | Hitachi High-Tech Corporation | Primer, dna detection method, and dna detection kit |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5066584A (en) | 1988-09-23 | 1991-11-19 | Cetus Corporation | Methods for generating single stranded dna by the polymerase chain reaction |
| US5210015A (en) | 1990-08-06 | 1993-05-11 | Hoffman-La Roche Inc. | Homogeneous assay system using the nuclease activity of a nucleic acid polymerase |
| US5994056A (en) * | 1991-05-02 | 1999-11-30 | Roche Molecular Systems, Inc. | Homogeneous methods for nucleic acid amplification and detection |
| US5756285A (en) * | 1991-09-27 | 1998-05-26 | Amersham Life Science, Inc. | DNA cycle sequencing |
| US5925517A (en) | 1993-11-12 | 1999-07-20 | The Public Health Research Institute Of The City Of New York, Inc. | Detectably labeled dual conformation oligonucleotide probes, assays and kits |
| US5538848A (en) | 1994-11-16 | 1996-07-23 | Applied Biosystems Division, Perkin-Elmer Corp. | Method for detecting nucleic acid amplification using self-quenching fluorescence probe |
| US5716784A (en) * | 1996-02-05 | 1998-02-10 | The Perkin-Elmer Corporation | Fluorescence detection assay for homogeneous PCR hybridization systems |
| JP3898228B2 (ja) | 1996-04-12 | 2007-03-28 | ザ パブリック ヘルス リサーチ インスティチュート オブ ザ シティー オブ ニューヨーク インク | 検出プローブ、キット及びアッセイ |
| WO1997046714A1 (en) * | 1996-06-04 | 1997-12-11 | University Of Utah Research Foundation | Monitoring hybridization during pcr |
| US5935791A (en) * | 1997-09-23 | 1999-08-10 | Becton, Dickinson And Company | Detection of nucleic acids by fluorescence quenching |
| GB9725197D0 (en) | 1997-11-29 | 1998-01-28 | Secr Defence | Detection system |
| US6140054A (en) * | 1998-09-30 | 2000-10-31 | University Of Utah Research Foundation | Multiplex genotyping using fluorescent hybridization probes |
| US6277607B1 (en) | 1999-05-24 | 2001-08-21 | Sanjay Tyagi | High specificity primers, amplification methods and kits |
| EP1210358A4 (en) | 1999-08-13 | 2005-01-05 | Univ Brandeis | DETECTION OF NUCLEIC ACIDS |
| US6472156B1 (en) | 1999-08-30 | 2002-10-29 | The University Of Utah | Homogeneous multiplex hybridization analysis by color and Tm |
| WO2001031062A1 (en) | 1999-10-22 | 2001-05-03 | The Public Health Research Institute Of The City Of New York, Inc. | Assays for short sequence variants |
| US20030082550A1 (en) * | 2000-09-08 | 2003-05-01 | Hans-Ulrich Thomann | Mutations of the cyclooxygenase-2 gene |
| US7267945B2 (en) * | 2001-03-26 | 2007-09-11 | Applera Corporation | Methods of determining the presence of polynucleotides employing amplification |
| GB0112868D0 (en) * | 2001-05-25 | 2001-07-18 | Secr Defence | Detection system |
| EP1436391A4 (en) * | 2001-06-08 | 2005-02-16 | Shanghai Mendel Dna Ct Co Ltd | CYCLIC EXTENSION AT LOW TEMPERATURE OF DNA WITH HIGH SPECIFICITY OF BEGINNING |
| US20030108906A1 (en) * | 2001-07-27 | 2003-06-12 | Brooksbank Robert Alan | Identification and use of molecules implicated in pain |
| EP1444365A4 (en) * | 2001-10-25 | 2005-07-20 | Gorilla Genomics Inc | ASYMMETRIC PCR WITH NUCLEASE-FREE POLYMERASE OR NUCLEASERESISTENT MOLECULAR BEACONS |
| AU2002346484A1 (en) | 2001-11-21 | 2003-06-10 | Optiscan Biomedical Corporation | Method and apparatus for improving the accuracy of alternative site analyte concentration measurements |
| US7198897B2 (en) | 2001-12-19 | 2007-04-03 | Brandeis University | Late-PCR |
| JP2004024035A (ja) * | 2002-06-21 | 2004-01-29 | Tosoh Corp | 核酸の検出方法 |
| EP1394271B1 (en) * | 2002-09-02 | 2007-11-14 | Toyo Boseki Kabushiki Kaisha | Method for identifying nucleotide polymorphisms using resonance energy transfer |
| WO2004048516A2 (en) * | 2002-11-22 | 2004-06-10 | North Shore-Long Island Jewish Research Institute | Elf3 gene compositions and methods |
| US20040175704A1 (en) * | 2003-03-06 | 2004-09-09 | Stratagene | Compositions and methods for polynucleotide sequence detection |
| CA2548205C (en) * | 2003-12-03 | 2017-06-27 | Abbott Laboratories | Double stranded linear nucleic acid probe and uses thereof |
| CN107988363A (zh) * | 2004-03-31 | 2018-05-04 | 综合医院公司 | 测定癌症对表皮生长因子受体靶向性治疗反应性的方法 |
| KR101424812B1 (ko) * | 2004-10-18 | 2014-08-07 | 브랜데이스 유니버시티 | 핵산 증폭을 위한 프라이머, 프로브 및 방법 |
-
2005
- 2005-10-17 KR KR1020077011244A patent/KR101424812B1/ko not_active Expired - Fee Related
- 2005-10-17 AT AT05810422T patent/ATE494295T1/de active
- 2005-10-17 CA CA2855748A patent/CA2855748C/en not_active Expired - Fee Related
- 2005-10-17 PT PT05810422T patent/PT1805199E/pt unknown
- 2005-10-17 ES ES14195859.5T patent/ES2668467T3/es not_active Expired - Lifetime
- 2005-10-17 EP EP05810422A patent/EP1805199B1/en not_active Expired - Lifetime
- 2005-10-17 DK DK05810422.5T patent/DK1805199T3/da active
- 2005-10-17 WO PCT/US2005/037667 patent/WO2006044994A2/en not_active Ceased
- 2005-10-17 ES ES05810422T patent/ES2359322T3/es not_active Expired - Lifetime
- 2005-10-17 JP JP2007537034A patent/JP5543065B2/ja not_active Expired - Lifetime
- 2005-10-17 DE DE602005025791T patent/DE602005025791D1/de not_active Expired - Lifetime
- 2005-10-17 EP EP14195859.5A patent/EP2927238B1/en not_active Expired - Lifetime
- 2005-10-17 KR KR1020137002325A patent/KR101347951B1/ko not_active Expired - Fee Related
- 2005-10-17 US US11/252,433 patent/US7632642B2/en not_active Expired - Lifetime
- 2005-10-17 CN CN200580042622XA patent/CN101076607B/zh not_active Expired - Lifetime
- 2005-10-17 CA CA2584569A patent/CA2584569C/en not_active Expired - Fee Related
- 2005-10-17 RU RU2007118545/10A patent/RU2460804C2/ru not_active IP Right Cessation
- 2005-10-17 AU AU2005295298A patent/AU2005295298B2/en not_active Ceased
- 2005-10-17 ES ES10187807.2T patent/ES2529204T3/es not_active Expired - Lifetime
- 2005-10-17 EP EP10187807.2A patent/EP2351766B1/en not_active Expired - Lifetime
- 2005-10-17 PL PL05810422T patent/PL1805199T3/pl unknown
- 2005-10-17 BR BRPI0517105-9A patent/BRPI0517105B1/pt not_active IP Right Cessation
- 2005-10-17 CA CA2996947A patent/CA2996947C/en not_active Expired - Fee Related
- 2005-10-17 KR KR1020137025318A patent/KR101447405B1/ko not_active Expired - Fee Related
-
2007
- 2007-05-15 NO NO20072506A patent/NO20072506L/no not_active Application Discontinuation
-
2008
- 2008-11-10 US US12/292,038 patent/US20120040352A1/en not_active Abandoned
-
2012
- 2012-08-01 US US13/564,528 patent/US9745624B2/en not_active Expired - Lifetime
-
2014
- 2014-01-06 JP JP2014000518A patent/JP5860484B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2855748C (en) | Primers, probes and methods for nucleic acid amplification | |
| US7348141B2 (en) | Hybridization beacon and method of rapid sequence detection and discrimination | |
| JP6688318B2 (ja) | 多重侵入切断アッセイ | |
| AU2001242634A1 (en) | Hybridisation beacon and method of rapid sequence detection and discrimination | |
| EP3234186A1 (en) | Mispriming prevention reagents | |
| HK1216762A1 (zh) | 用於表徵ssdna序列的dsdna結合染料和探針的組合 | |
| HK1106251B (en) | Methods for nucleic acid amplification |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20140704 |
|
| MKLA | Lapsed |
Effective date: 20211018 |